Gritstone Bio - Stock Price History | GRTS

Historical daily share price chart and data for Gritstone Bio since 2022 adjusted for splits. The latest closing stock price for Gritstone Bio as of August 12, 2022 is 4.10.
  • The all-time high Gritstone Bio stock closing price was 31.10 on December 06, 2018.
  • The Gritstone Bio 52-week high stock price is 14.42, which is 251.7% above the current share price.
  • The Gritstone Bio 52-week low stock price is 1.71, which is 58.3% below the current share price.
  • The average Gritstone Bio stock price for the last 52 weeks is 6.49.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Gritstone Bio Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 10.7689 4.0700 27.1100 4.0700 12.8600 226.40%
2020 5.4383 8.1300 11.3000 2.5700 3.9400 -56.08%
2019 10.7768 16.2900 18.9600 7.0700 8.9700 -41.94%
2018 19.0064 14.2400 31.1000 11.6100 15.4500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.299B $0.048B
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars - first, a proprietary machine learning-based platform, Gritstone EDGE(TM), which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient?s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients? TSNA to drive the patient?s immune system to attack and destroy tumors.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.361B 9.79
GSK (GSK) United Kingdom $73.273B 8.80
Bio-Rad Laboratories (BIO.B) United States $15.412B 34.05
QIAGEN (QGEN) Netherlands $11.336B 18.98
Biohaven Pharmaceutical Holding (BHVN) United States $10.564B 0.00
Ginkgo Bioworks Holdings (DNA) United States $6.449B 0.00
Arcus Biosciences (RCUS) United States $1.963B 38.31
Myovant Sciences (MYOV) United Kingdom $1.774B 0.00
Emergent Biosolutions (EBS) United States $1.521B 8.82
Zymeworks (ZYME) Canada $0.430B 0.00
Enzo Biochem (ENZ) United States $0.130B 0.00
Gelesis Holdings (GLS) United States $0.118B 0.00
SQZ Biotechnologies (SQZ) United States $0.099B 0.00
Ambrx Biopharma (AMAM) United States $0.095B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00